Search

Author/Creator Lomovskaya, Olga

1. 1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases. (4th December 2021)

Authors:
Lindley, Jill; Edah, Yahse; Lomovskaya, Olga; Castanheira, Mariana; Castanheira, Mariana
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases. (4th December 2021)

Authors:
Lindley, Jill; Edah, Yahse; Lomovskaya, Olga; Castanheira, Mariana; Castanheira, Mariana
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 166. Activity of a Novel β-lactamase Inhibitor QPX7728 Combined With β-lactams Against st258 klebsiella Pneumoniae and st131 escherchia Coli Isolates Producing β-lactamases. (31st December 2020)

Authors:
Castanheira, Mariana; Lindley, Jill; Doyle, Timothy B; Davis, Andrew P; Lomovskaya, Olga
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Assessment of MIC Increases with Meropenem-Vaborbactam and Ceftazidime-Avibactam in TANGO II (a Phase 3 Study of the Treatment of CRE Infections). (4th October 2017)

Authors:
Lomovskaya, Olga; Castanheira, Mariana; Vazquez, Jose; Kaye, Keith S; Nelson, Kirk; Sun, Dongxu; Alexander, Elizabeth; Dudley, Michael N; Yin, Michael
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis. (4th October 2017)

Authors:
Walsh, Thomas J; Bhowmick, Tanaya; Darouiche, Rabih; Zaitsev, Valerii; Giamarellos-Bourboulis, Evangelos; Shorr, Andrew F; Fedosiuk, Elena; File, Thomas M; Loutit, Jeffrey S; Lomovskaya, Olga; Dudley, Michael N; Perlin, David
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S536
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Meropenem–Vaborbactam Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses as Support for Dose Selection in Patients with Normal Renal Function and Varying Degrees of Renal Impairment. (4th October 2017)

Authors:
Bhavnani, Sujata M; Trang, Michael; Griffith, David C; Lomovskaya, Olga; Hammel, Jeffrey P; Loutit, Jeffrey S; Dudley, Michael N; Ambrose, Paul G; Rubino, Christopher M
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗